tradingkey.logo

Truist Securities downgrades Penumbra on Boston Scientific's $14.5 billion buyout

ReutersJan 16, 2026 7:27 PM

Truist Securities downgrades medical equipment maker Penumbra PEN.N to "hold" from "buy"

Boston Scientific BSX.N said on Thursday that it will buy PEN in a deal valued at about $14.5 billion

We don't see any major hurdles to this deal closing and believe it will be hard to top BSX given the smooth strategic fit, brokerage says

11 of 19 brokerages rate the stock "buy" and 8 "hold"; their median PT is $370

Including session's move, PEN up 34% in the last 12 months

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI